0 false false false false false false false false false false true false false false false true false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 09913149 2024-01-01 2024-12-31 09913149 2024-12-31 09913149 2023-12-31 09913149 2023-01-01 2023-12-31 09913149 2023-12-31 09913149 2022-12-31 09913149 bus:Director1 2024-01-01 2024-12-31 09913149 core:WithinOneYear 2024-12-31 09913149 core:WithinOneYear 2023-12-31 09913149 bus:Micro-entities 2024-01-01 2024-12-31 09913149 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 09913149 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 09913149 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 09913149 bus:FullAccounts 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: 09913149
Nikola Medical Ltd
Filleted Unaudited Financial Statements
31 December 2024
Nikola Medical Ltd
Financial Statements
Year ended 31 December 2024
Contents
Page
Balance sheet and the notes to the financial statements
1
Nikola Medical Ltd
Balance Sheet
31 December 2024
2024
2023
£
£
Current assets
16,108
44,128
Creditors: amounts falling due within one year
14,923
26,795
--------
--------
Net current assets
1,185
17,333
-------
--------
Total assets less current liabilities
1,185
17,333
Accruals and deferred income
1,183
1,165
-------
--------
2
16,168
-------
--------
Capital and reserves
2
16,168
----
--------
Notes to the financial statements
1. Basis of preparation
The financial statements have been prepared on the historical cost basis.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Monetary amounts in these financial statements are rounded to the nearest £.
2. Employee numbers
The average number of persons employed by the company during the year amounted to Nil (2023: Nil).
3. Cessation
The company ceased to trade on 31 December 2024.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 2 April 2025 , and are signed on behalf of the board by:
Dr N Tsakampikas
Director
Company registration number: 09913149
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 29 King Street, Newcastle-under-Lyme, Staffordshire, ST5 1ER, United Kingdom.